Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Growth (Status and Outlook) 2025-2031

December 2025 | 79 pages | ID: G455F70B2031EN
LP Information

Abstracts

According to this study, the global Phosphoinositide 3-Kinase (PI3K) Inhibitors market size will reach US$ million by 2031.

PI3K inhibitors work by inhibiting PI3K enzymes, which helps in signaling the pathway for cellular functions such as growth control, metabolism, and translation initiation.

There is extensive ongoing research on targeted therapies such as PI3K inhibitors with proven efficacy in oncology applications.The significant R&D in prevailing class of therapeutics has given rise to targeted therapies.

LPI (LP Information)' newest research report, the “Phosphoinositide 3-Kinase (PI3K) Inhibitors Industry Forecast” looks at past sales and reviews total world Phosphoinositide 3-Kinase (PI3K) Inhibitors sales in 2024, providing a comprehensive analysis by region and market sector of projected Phosphoinositide 3-Kinase (PI3K) Inhibitors sales for 2025 through 2031. With Phosphoinositide 3-Kinase (PI3K) Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phosphoinositide 3-Kinase (PI3K) Inhibitors industry.

This Insight Report provides a comprehensive analysis of the global Phosphoinositide 3-Kinase (PI3K) Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Phosphoinositide 3-Kinase (PI3K) Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Phosphoinositide 3-Kinase (PI3K) Inhibitors market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phosphoinositide 3-Kinase (PI3K) Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phosphoinositide 3-Kinase (PI3K) Inhibitors.

This report presents a comprehensive overview, market shares, and growth opportunities of Phosphoinositide 3-Kinase (PI3K) Inhibitors market by product type, application, key players and key regions and countries.

Segmentation by Type:

• CLL - Chronic Iymphocytic Ieukemia
• FL - Follicular Iymphoma
• Other Indications

Segmentation by Application:

• hospital
• Research Institutes and Research Institutions
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Bayer AG
• Gilead Sciences Inc.
• Novartis AG
• TG Therapeutics Inc.
• Verastem Inc.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2020-2031)
  2.1.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Phosphoinositide 3-Kinase (PI3K) Inhibitors by Country/Region (2020, 2024 & 2031)
2.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Segment by Type
  2.2.1 CLL - Chronic Iymphocytic Ieukemia
  2.2.2 FL - Follicular Iymphoma
  2.2.3 Other Indications
2.3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
  2.3.1 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Type (2020-2025)
2.4 Phosphoinositide 3-Kinase (PI3K) Inhibitors Segment by Application
  2.4.1 hospital
  2.4.2 Research Institutes and Research Institutions
  2.4.3 Clinic
  2.4.4 Other
2.5 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application
  2.5.1 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Application (2020-2025)

3 PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS MARKET SIZE BY PLAYER

3.1 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Player
  3.1.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue by Player (2020-2025)
  3.1.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Player (2020-2025)
3.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS BY REGION

4.1 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2020-2025)
4.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Annual Revenue by Country/Region (2020-2025)
4.3 Americas Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth (2020-2025)
4.4 APAC Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth (2020-2025)
4.5 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth (2020-2025)
4.6 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2020-2025)
5.2 Americas Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2020-2025)
5.3 Americas Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2020-2025)
6.2 APAC Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2020-2025)
6.3 APAC Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2020-2025)
7.2 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2020-2025)
7.3 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors by Region (2020-2025)
8.2 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2020-2025)
8.3 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS MARKET FORECAST

10.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast by Region (2026-2031)
  10.1.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast by Region (2026-2031)
  10.1.2 Americas Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
  10.1.3 APAC Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
  10.1.4 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
  10.1.5 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
10.2 Americas Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast by Country (2026-2031)
  10.2.1 United States Market Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
  10.2.2 Canada Market Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
  10.2.3 Mexico Market Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
  10.2.4 Brazil Market Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
10.3 APAC Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast by Region (2026-2031)
  10.3.1 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Forecast
  10.3.2 Japan Market Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
  10.3.3 Korea Market Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
  10.3.4 Southeast Asia Market Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
  10.3.5 India Market Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
  10.3.6 Australia Market Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
10.4 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast by Country (2026-2031)
  10.4.1 Germany Market Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
  10.4.2 France Market Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
  10.4.3 UK Market Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
  10.4.4 Italy Market Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
  10.4.5 Russia Market Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
10.5 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast by Region (2026-2031)
  10.5.1 Egypt Market Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
  10.5.2 South Africa Market Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
  10.5.3 Israel Market Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
  10.5.4 Turkey Market Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast
10.6 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast by Type (2026-2031)
10.7 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecast

11 KEY PLAYERS ANALYSIS

11.1 Bayer AG
  11.1.1 Bayer AG Company Information
  11.1.2 Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Offered
  11.1.3 Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Bayer AG Main Business Overview
  11.1.5 Bayer AG Latest Developments
11.2 Gilead Sciences Inc.
  11.2.1 Gilead Sciences Inc. Company Information
  11.2.2 Gilead Sciences Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Offered
  11.2.3 Gilead Sciences Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Gilead Sciences Inc. Main Business Overview
  11.2.5 Gilead Sciences Inc. Latest Developments
11.3 Novartis AG
  11.3.1 Novartis AG Company Information
  11.3.2 Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Offered
  11.3.3 Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Novartis AG Main Business Overview
  11.3.5 Novartis AG Latest Developments
11.4 TG Therapeutics Inc.
  11.4.1 TG Therapeutics Inc. Company Information
  11.4.2 TG Therapeutics Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Offered
  11.4.3 TG Therapeutics Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 TG Therapeutics Inc. Main Business Overview
  11.4.5 TG Therapeutics Inc. Latest Developments
11.5 Verastem Inc.
  11.5.1 Verastem Inc. Company Information
  11.5.2 Verastem Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Offered
  11.5.3 Verastem Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Verastem Inc. Main Business Overview
  11.5.5 Verastem Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Phosphoinositide 3-Kinase (PI3K) Inhibitors Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of CLL - Chronic Iymphocytic Ieukemia
Table 4. Major Players of FL - Follicular Iymphoma
Table 5. Major Players of Other Indications
Table 6. Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Type (2020-2025)
Table 9. Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Application (2020-2025)
Table 12. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Player (2020-2025)
Table 14. Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players Head office and Products Offered
Table 15. Phosphoinositide 3-Kinase (PI3K) Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Region (2020-2025)
Table 20. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Country (2020-2025)
Table 24. Americas Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Type (2020-2025)
Table 26. Americas Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Application (2020-2025)
Table 28. APAC Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Region (2020-2025)
Table 30. APAC Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Country (2020-2025)
Table 34. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Phosphoinositide 3-Kinase (PI3K) Inhibitors
Table 40. Key Market Challenges & Risks of Phosphoinositide 3-Kinase (PI3K) Inhibitors
Table 41. Key Industry Trends of Phosphoinositide 3-Kinase (PI3K) Inhibitors
Table 42. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Bayer AG Details, Company Type, Phosphoinositide 3-Kinase (PI3K) Inhibitors Area Served and Its Competitors
Table 47. Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Offered
Table 48. Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Bayer AG Main Business
Table 50. Bayer AG Latest Developments
Table 51. Gilead Sciences Inc. Details, Company Type, Phosphoinositide 3-Kinase (PI3K) Inhibitors Area Served and Its Competitors
Table 52. Gilead Sciences Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Offered
Table 53. Gilead Sciences Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Gilead Sciences Inc. Main Business
Table 55. Gilead Sciences Inc. Latest Developments
Table 56. Novartis AG Details, Company Type, Phosphoinositide 3-Kinase (PI3K) Inhibitors Area Served and Its Competitors
Table 57. Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Offered
Table 58. Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Novartis AG Main Business
Table 60. Novartis AG Latest Developments
Table 61. TG Therapeutics Inc. Details, Company Type, Phosphoinositide 3-Kinase (PI3K) Inhibitors Area Served and Its Competitors
Table 62. TG Therapeutics Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Offered
Table 63. TG Therapeutics Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. TG Therapeutics Inc. Main Business
Table 65. TG Therapeutics Inc. Latest Developments
Table 66. Verastem Inc. Details, Company Type, Phosphoinositide 3-Kinase (PI3K) Inhibitors Area Served and Its Competitors
Table 67. Verastem Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Offered
Table 68. Verastem Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Verastem Inc. Main Business
Table 70. Verastem Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Phosphoinositide 3-Kinase (PI3K) Inhibitors Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Phosphoinositide 3-Kinase (PI3K) Inhibitors Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Phosphoinositide 3-Kinase (PI3K) Inhibitors Sales Market Share by Country/Region (2024)
Figure 8. Phosphoinositide 3-Kinase (PI3K) Inhibitors Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Type in 2024
Figure 10. Phosphoinositide 3-Kinase (PI3K) Inhibitors in hospital
Figure 11. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market: hospital (2020-2025) & ($ millions)
Figure 12. Phosphoinositide 3-Kinase (PI3K) Inhibitors in Research Institutes and Research Institutions
Figure 13. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market: Research Institutes and Research Institutions (2020-2025) & ($ millions)
Figure 14. Phosphoinositide 3-Kinase (PI3K) Inhibitors in Clinic
Figure 15. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market: Clinic (2020-2025) & ($ millions)
Figure 16. Phosphoinositide 3-Kinase (PI3K) Inhibitors in Other
Figure 17. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market: Other (2020-2025) & ($ millions)
Figure 18. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Application in 2024
Figure 19. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Player in 2024
Figure 20. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Region (2020-2025)
Figure 21. Americas Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2020-2025 ($ millions)
Figure 22. APAC Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2020-2025 ($ millions)
Figure 23. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2020-2025 ($ millions)
Figure 25. Americas Phosphoinositide 3-Kinase (PI3K) Inhibitors Value Market Share by Country in 2024
Figure 26. United States Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Region in 2024
Figure 31. APAC Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Type (2020-2025)
Figure 32. APAC Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Application (2020-2025)
Figure 33. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 37. India Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Country in 2024
Figure 40. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Type (2020-2025)
Figure 41. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Application (2020-2025)
Figure 42. Germany Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 43. France Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 56. APAC Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 57. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 59. United States Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 60. Canada Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 61. Mexico Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 62. Brazil Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 63. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 64. Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 65. Korea Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 67. India Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 68. Australia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 69. Germany Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 70. France Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 71. UK Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 72. Italy Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 73. Russia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 74. Egypt Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 75. South Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 76. Israel Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 77. Turkey Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)
Figure 78. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size 2026-2031 ($ millions)